vitiligo
Showing 26 - 50 of 169
Tregs CD25 CXCL9 in Vitiligo
Not yet recruiting
- Vitiligo
- +3 more
- ELIZA , Flowcytometry
- (no location specified)
Oct 3, 2022
How Does Skin Tone Affect Quantitative Photoacoustic Imaging
Not yet recruiting
- Vitiligo
- Skin Abnormalities
- Photoacoustic imaging
- (no location specified)
Sep 23, 2022
Vitiligo Trial in Sohag (serum leptin)
Not yet recruiting
- Vitiligo
- serum leptin
-
Sohag, EgyptSohag University Hospital
Sep 18, 2022
Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)
Not yet recruiting
- Autoimmune Diseases
- +10 more
- Blood sample taken at a single time point
- (no location specified)
Sep 14, 2022
Vitiligo, Topical Fluorouracil, Effervescent Mixture Trial in Cairo (a new effervescent mixture 5-florouracil formula,
Not yet recruiting
- Vitiligo
- +2 more
- a new effervescent mixture 5-florouracil formula
- 5-Fluorouracil plain powder
-
Cairo, EgyptFacualty of Pharmacy, Al Azhar University
Sep 12, 2022
Vitiligo Trial in Nice (Glisodin tablet, Placebo tablet)
Completed
- Vitiligo
- Glisodin tablet
- Placebo tablet
-
Nice, Alpes-Maritime, FrancePasseron
Aug 30, 2022
Vitiligo Trial in Qina (Latanoprost 0.005% Ophthalmic Solution, 5Fluorouracil)
Active, not recruiting
- Vitiligo
- Latanoprost 0.005% Ophthalmic Solution
- 5Fluorouracil
-
Qinā, Qena Governorate, EgyptSouth Valley University
Aug 22, 2022
Tissue-resident Memory T Cells Expression Among Repigmentation
Completed
- Vitiligo
-
San Luis Potosí, MexicoDermatology Department. Hospital Central "Dr. Ignacio Morones Pr
Aug 16, 2022
Vitiligo Trial in United States (ARQ-252 cream 0.3%, ARQ-252 Vehicle cream, NB-UVB phototherapy active treatment)
Terminated
- Vitiligo
- ARQ-252 cream 0.3%
- +3 more
-
San Diego, California
- +4 more
Aug 4, 2022
Vitiligo Trial in Charleston (Bimatoprost, Excimer laser, Microneedling with a dermaroller)
Completed
- Vitiligo
- Bimatoprost
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Aug 3, 2022
Vitiligo Trial in Charleston (Rapamycin, Placebo)
Recruiting
- Vitiligo
- Rapamycin
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Aug 2, 2022
Vitiligo Trial in Sohag (derma pen)
Not yet recruiting
- Vitiligo
- derma pen
-
Sohag, EgyptSohag University Hospital
Jul 20, 2022
Vitiligo Trial in China (Low Dose SHR0302 Ointment BID, High Dose SHR0302 Ointment BID, Placebo Comparator: Vehicle)
Terminated
- Vitiligo
- Low Dose SHR0302 Ointment BID
- +2 more
-
Fuzhou, Fujian, China
- +15 more
Jul 11, 2022
Vitiligo, JAK Inhibitor Trial in Canada, United States (Ruxolitinib 1.5% cream, NB-UVB phototherapy)
Recruiting
- Vitiligo
- JAK Inhibitor
- Ruxolitinib 1.5% cream
- NB-UVB phototherapy
-
Fountain Valley, California
- +13 more
Jul 6, 2022
Vitiligo, Dermatology/Skin - Other Trial in Baltimore (Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet)
Active, not recruiting
- Vitiligo
- Dermatology/Skin - Other
- Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jun 28, 2022
Vitiligo Trial in Nice, Bordeaux (The resident memory T-cell infiltrate in perilesional vitiligo skin)
Recruiting
- Vitiligo
- The resident memory T-cell infiltrate in perilesional vitiligo skin
-
Nice, Alpes Maritimes, France
- +1 more
Jun 14, 2022
Vitamin D Deficiency, Vitiligo Trial in Seoul (cholecalciferol (vitamin D3), Phototherapy)
Completed
- Vitamin D Deficiency
- Vitiligo
- cholecalciferol (vitamin D3)
- Phototherapy
-
Seoul, Korea, Republic ofKangnam Sacred Heart Hospital
May 3, 2022
Skin and Connective Tissue Diseases, Skin Diseases, Pigmentation Disorder Trial in Sydney (Tildrakizumab)
Recruiting
- Skin and Connective Tissue Diseases
- +5 more
-
Sydney, New South Wales, AustraliaPremier Specialists Pty Ltd
Apr 19, 2022
Ocular Changes in Vitiligo Patients on Therapy
Recruiting
- Vitiligo
- +2 more
- Optical coherence tomography angiography (OCT-A)
-
Banhā, QA, EgyptBenha University
Apr 17, 2022
The Gut and Skin Microbiome in Vitiligo Disease Progression
Recruiting
- Vitiligo
- Healthy
-
Chicago, IllinoisNorthwestern University
Apr 5, 2022
Vitiligo Trial (Crisaborole 2 % Topical Ointment, PF-07038124 0.01% topical ointment, NBUVB phototherapy)
Not yet recruiting
- Vitiligo
- Crisaborole 2 % Topical Ointment
- +4 more
- (no location specified)
Mar 17, 2022
Vitiligo Trial in Canada, France, United States (Ruxolitinib cream, Vehicle Cream)
Recruiting
- Vitiligo
- Ruxolitinib cream
- Vehicle Cream
-
Fountain Valley, California
- +12 more
Mar 24, 2022
Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)
Not yet recruiting
- Vitiligo
- Effect of Drug
- JAK-2 inhibitor
- Topical corticosteroid
- (no location specified)
Mar 19, 2022